Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Zhukov v. AstraZeneca plc et al
Case Number:
1:21-cv-00825
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
September 12, 2022
AstraZeneca Beats Investors' COVID Vaccine Suit For Good
A New York federal judge on Monday permanently dismissed a proposed class action alleging AstraZeneca misled investors about the progress of clinical trials for its COVID-19 vaccine, finding the investors didn't identify any misleading statement from the company or show fraudulent intent.
-
April 30, 2021
Robbins Geller, Pomerantz To Lead AstraZeneca Investor Suit
Robbins Geller Rudman & Dowd LLP and Pomerantz LLP have been tapped to represent AstraZeneca investors in a Manhattan federal court suit alleging the company withheld information about problems in the clinical trial of its COVID-19 vaccine.
-
January 29, 2021
AstraZeneca Hit With Investor Suit Over COVID-19 Vaccine
An AstraZeneca investor filed a putative class action in New York federal court Friday accusing the biopharmaceutical giant of withholding information about its COVID-19 vaccine candidate, misleading the public about the progress and adequacy of its clinical trial.